0000950170-24-032237.txt : 20240315
0000950170-24-032237.hdr.sgml : 20240315
20240315163147
ACCESSION NUMBER: 0000950170-24-032237
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240315
FILED AS OF DATE: 20240315
DATE AS OF CHANGE: 20240315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pitt Justin D
CENTRAL INDEX KEY: 0001900988
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15925
FILM NUMBER: 24755322
MAIL ADDRESS:
STREET 1: 4000 MERIDIAN BOULEVARD
CITY: FRANKLIN
STATE: TN
ZIP: 37067
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC
CENTRAL INDEX KEY: 0001108109
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 133893191
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4000 MERIDIAN BOULEVARD
CITY: FRANKLIN
STATE: TN
ZIP: 37067
BUSINESS PHONE: 615-465-7000
MAIL ADDRESS:
STREET 1: 4000 MERIDIAN BOULEVARD
CITY: FRANKLIN
STATE: TN
ZIP: 37067
FORMER COMPANY:
FORMER CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC/
DATE OF NAME CHANGE: 20000229
4
1
ownership.xml
4
X0508
4
2024-03-15
0001108109
COMMUNITY HEALTH SYSTEMS INC
CYH
0001900988
Pitt Justin D
4000 MERIDIAN BOULEVARD
FRANKLIN
TN
37067
false
true
false
false
EVP and General Counsel
false
Common Stock
2024-03-15
4
D
false
5001
0
D
12584
I
By spouse
Common Stock
208116
D
Performance Based Restricted
0
Common Stock
30000
30000
D
Performance Based Restricted
0
Common Stock
30000
30000
D
Performance Based Restricted
0
Common Stock
30000
30000
D
Stock Options (Right to Buy)
4.99
2020-03-01
2029-02-28
Common Stock
5000
5000
D
Stock Options (Right to Buy)
4.93
2021-03-01
2030-02-28
Common Stock
20000
20000
D
Stock Options (Right to Buy)
8.81
2022-03-01
2031-02-28
Common Stock
20000
20000
D
Stock Options (Right to Buy)
10.18
2023-03-01
2032-02-29
Common Stock
30000
30000
D
Stock Options (Right to Buy)
6.15
2024-03-01
2033-02-28
Common Stock
30000
30000
D
Stock Options (Right to Buy)
2.87
2025-03-01
2034-02-28
Common Stock
30000
30000
D
The Reporting Person's spouse is no longer employed by an affiliate of the Issuer. The remaining unvested portion of her prior awards of restricted stock was forfeited in conjunction with her ceasing to be employed by an affiate of the Issuer. The Reporting Person disclaims beneficial ownership of the securities of the Issuer owned by his spouse, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period.
The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2023 and 12/31/2025 (the "2023-2025 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2023-2025 Performance Period.
The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.
Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.
Christopher G. Cobb, Attorney in Fact for Justin D. Pitt
2024-03-15